CABA (Cabaletta Bio Inc.) Sof foyda

CABA (Cabaletta Bio) - kompaniyaning tovar belgisi

Cabaletta Bio, Inc. (CABA) aksiyalarining retrospektiv narxi autoimmun patologiyalarga qarshi kurashish uchun CAR-T terapiyalarini ishlab chiqayotgan kompaniyaning trayektoriyasini aks ettiradi. Intellektual mulk himoyasi va FDA ning qat'iy tartibga soluvchi qoidalari biznes uchun kuchli raqobatbardoshlik ustunligini yaratadi. Joriy ko'rsatkich -0.18 darajasida turibdi. Shu bilan birga, takrorlanuvchi daromadning yo'qligi va yuqori R&D xarajatlari pul oqimlarini oldindan aytib bo'lmaydigan holga keltirib, operatsion barqarorlikka to'sqinlik qilmoqda.

CABA (Cabaletta Bio, Inc.) Sof foyda tarixi 04.07.2022dan 29.10.2026gacha

Cabaletta Bio (CABA) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Cabaletta Bio Inc|CABA - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Cabaletta Bio Inc|CABA - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Cabaletta Bio, Inc.|CABA - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi cabalettabio.com|CABA - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Cabaletta Bio, Inc.|CABA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Cabaletta Bio Inc.|CABA - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Cabaletta Bio Inc|CABA - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Cabaletta Bio, Inc.|Shoshilinch likvidlik cabalettabio.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
CABA - Sof foyda
Kompaniyaning jamlanma tahlili:Cabaletta Bio, Inc.
Cabaletta Bio, Inc asosiy tovari

Cabaletta Bio, Inc. (CABA) kompaniyasining immunologik dori vositalarini ishlab chiqish natijalari kompaniyaning joriy sof foyda dinamikasida aks etgan. Ushbu ko'rsatkich bozor shovqinlarini filtrlab, operatsion samaradorlikning barqaror vektorini yoritib beradi. Hisob-kitoblar umumiy daromadlar va barcha operatsion xarajatlar orasidagi farqning kunlik aniqlanishiga asoslangan. Ushbu ko'rsatkichning barqarorligi biofarmatsevtika sektorining sanksiyalarga chidamliligi bilan ta'minlanadi. AQSHdagi klinik sinovlarning huquqiy xavfsizligi biznesning fundamental risklarini minimallashtiradi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|Pharming Corp (PHAR) - Sof daromad|NKTR: Sof foyda|upstreambio.com (UPB) - Sof foyda|ZBIO (Zenas Biopharma) - Sof foyda|Kompaniyaning sof foydasi IMNM|Sof foyda GOSS|Sof foyda KalVista Corp (KALV)|Kompaniyaning sof foydasi Septerna Inc SEPN|pieris.com - Kompaniyaning sof foydasi|Savara - Sof foyda|Kompaniyaning sof daromadi Rigel Pharma|ANAB (AnaptysBio Corp) - Sof daromad|ATXS: Soliqlar to‘langandan keyingi foyda|Sof daromad ENGN|RAPT (rapt.com) - Soliqlar to‘langandan keyingi foyda|Sof foyda JBIO|Sof foyda Aclaris Therapeutics Inc. (ACRS)|Kyverna - Sof daromad|Yakuniy foyda TLSA|Ventyx Biosciences - Sof foyda|THTX: Kompaniyaning sof foydasi|AVTX: Sof foyda|ELDN - Sof moliyaviy natija|Kompaniyaning sof foydasi Agenus Inc|Kompaniyaning sof daromadi Climb Bio, Inc CLYM|Sof daromad ZURA (Zura Bio Limited)|ATYR (atyrpharma.com) - Yakuniy foyda|Sof foyda ADAG (Adagene Inc.)|Sof moliyaviy natija ImageneBio (IMA)|STTK - Kompaniyaning sof foydasi|EQ (Equillium, Inc.) - Kompaniya foydasi|CNTB: Sof foyda|Sof daromad Immunic|Sof daromad ATRA|InflaRx GmbH (IFRX) - Sof moliyaviy natija|Sof foyda XFOR|Sof daromad adicetbio.com ACET|Sof foyda CELU (Celularity)|Sof foyda inmunebio.com INMB|Barinthus Biotherapeutics plc - Sof foyda|KZR: Kompaniyaning sof foydasi|SABS: Sof foyda|Akari Therapeutics, Plc (AKTX) - Sof foyda|Kompaniyaning sof foydasi Enlivex Therapeutics Ltd|Q32 Bio Corp - Soliqdan keyingi foyda|Sof foyda GOVX|EDSA (Edesa Biotech Inc) - Yakuniy foyda|Sof foyda IBIO (iBio Corp)|Sof foyda Carisma Therapeutics Inc CARM|XTLB - Kompaniyaning sof foydasi|Yakuniy foyda BOLT (Bolt Biotherapeutics)|hcwbiologics.com (HCWB) - Kompaniyaning sof foydasi|Sof daromad Aptevo Therapeutics Inc.|AIM (AIM ImmunoTech) - Sof foyda|Sof foyda Aditxt Corp|Sof daromad GRI (GRI Bio, Inc.)|XRTX (xortx.com) - Yakuniy foyda|Sof foyda HIND (Vyome Holdings)|Sof moliyaviy natija Revelation Biosciences Inc (REVB)|INDP - Kompaniyaning sof foydasi|BiondVax Pharmaceuticals (SCNI) - Sof daromad|calcimedica.com (CALI) - Kompaniyaning sof foydasi|Sof daromad Affimed N.V.|Sof daromad ALLK|Sof foyda HOOKIPA|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|iTeos Pharma - Kompaniya foydasi|Sof foyda OCEA (Ocean Biomedical, Inc.)|tcbiopharm.com (TCBP) - Kompaniyaning sof daromadi|Third Harmonic Bio, Inc. - Sof foyda